Published: 9 April 2025.
Related video
This content is hosted on YouTube. The player remains disabled until you choose to load it.
When you enable it, YouTube receives connection data and may use cookies or similar technologies to provide the service, measure its use and personalise content or advertising. Read YouTube's privacy information.
Accept and load YouTube · Keep disabled · Disable YouTube
Open on YouTube (external site)
Your choice is not saved. Until you enable it, this block does not load resources from the provider.
What is bariatric surgery, and how does it help control type 2 diabetes?
Type 2 diabetes affects more people in our society every day — almost like a silent epidemic advancing unchecked. This is a serious concern. The condition, which is closely linked to obesity, can cause serious complications if it is not managed well. Conventional treatments include medication, dietary changes and physical exercise, but these approaches sometimes fall short.
Bariatric surgery offers a solution for patients who have both obesity and type 2 diabetes. This surgical procedure reduces the size of the stomach and, in some cases, changes its connection to the intestine. These anatomical changes produce beneficial metabolic effects that go beyond weight loss alone.
Metabolic surgery can improve type 2 diabetes control and, in some people, achieve remission. Changes in hormones and insulin sensitivity can begin before substantial weight loss; the outcome depends on factors including the duration of diabetes and the pancreas's remaining functional capacity.
Who would have thought that changing the anatomy of the digestive system could have such a powerful effect on blood glucose control? Surprising, isn't it?

Five key benefits of bariatric surgery for patients with type 2 diabetes
1. The possibility of type 2 diabetes remission
According to the 2021 international consensus, remission means maintaining an HbA1c below 6.5% for at least three months without the usual glucose-lowering medication. It does not mean a cure: diabetes can return, and monitoring of blood glucose and possible complications must continue.
Remission may last for years or be lost over time. The likelihood varies according to the procedure, the duration of diabetes, previous insulin use and other factors; there is no single percentage that applies to every patient.
2. A significant reduction in diabetes medication
Even if remission is not achieved, medication requirements may decrease. The team must adjust doses from the perioperative period onwards to prevent hypoglycaemia. Do not stop insulin or other treatments on your own.
Reducing medication may be possible for some patients. However, certain treatments may still be indicated for cardiovascular, kidney or other reasons; whether they should continue, and at what doses, must be reviewed individually.
3. Improvement in associated cardiovascular risk factors
Obesity surgery benefits blood glucose control and other cardiovascular risk factors that often accompany type 2 diabetes. After surgery, marked improvements are seen in high blood pressure, cholesterol and triglyceride levels, and sleep apnoea.
Improving these factors may reduce cardiovascular risk. Their progress is reviewed alongside diabetes treatment, smoking, physical activity and other influences, without promising a fixed reduction in an individual's risk.
4. Sustainable long-term weight loss
Bariatric surgery can achieve sustained weight loss, although weight regain can occur. The amount depends on the procedure, the patient and the length of follow-up. The percentage of excess weight lost is not the same as the percentage of total weight lost.
Weight reduction may improve insulin sensitivity. Follow-up allows changes to be identified and treatment to be adapted; the course of diabetes should not be attributed entirely to weight alone.
5. Improvement in quality of life and longevity
Mobility and quality of life may improve after surgery, although physical and emotional outcomes vary. Anxiety or depression require specific attention when they occur.
Follow-up studies describe long-term health benefits in selected patients. They do not allow a specific number of additional years of life to be promised to an individual.
Types of bariatric surgery recommended for patients with diabetes
Gastric bypass: the procedure with the strongest scientific evidence
Gastric bypass is currently the surgical procedure with the strongest scientific support for treating type 2 diabetes — something of a flagship for metabolic surgery. It combines a reduction in stomach size with a change in the route food takes through the intestine, producing a powerful metabolic effect.
In this procedure, a small stomach pouch is created and connected directly to the small intestine, bypassing part of the stomach and duodenum. This anatomical change produces hormonal changes that rapidly improve blood glucose control, even before significant weight loss occurs.
The likelihood of remission after bypass depends on the initial metabolic situation and the length of follow-up. The choice takes account of expected benefits, risks, and medical and surgical alternatives.
Sleeve gastrectomy: an alternative with its own risks
Sleeve gastrectomy reduces the size of the stomach by removing approximately 80% of it, leaving a tube-shaped stomach. Although technically simpler than bypass, it has also shown excellent results in controlling type 2 diabetes.
This procedure works through several mechanisms: it reduces stomach capacity, lowers production of ghrelin — the hunger hormone — and speeds up gastric emptying, changing the secretion of intestinal hormones that improve glucose metabolism.
Sleeve gastrectomy can also improve blood glucose control, but a recent diagnosis of diabetes or a particular degree of obesity is not enough to choose it. Reflux, medical history and follow-up needs influence the decision.
Who may be a candidate for bariatric surgery as a treatment for diabetes?
The decision is individualised. The 2022 ASMBS/IFSO recommendations advise considering metabolic surgery for people with type 2 diabetes and a BMI of 30 kg/m² or above. BMI does not replace assessment of the clinical situation, surgical risk and alternatives.
The duration of diabetes, medication, remaining insulin secretion capacity and existing complications are also considered. An insurer's coverage criteria may differ from clinical recommendations.
Clinical, nutritional and, where appropriate, psychological assessment helps select treatment and reduce risks. No assessment process can guarantee the outcome.
Recovery after bariatric surgery
Recovery and length of hospital stay depend on the procedure and how the patient progresses. Return to work is tailored to the type of activity and any complications; it cannot be guaranteed within a fixed period.
During the first few weeks, the patient follows a progressive diet supervised by nutrition professionals, moving from liquids to purées and eventually solid foods. This gradual adjustment is crucial to avoid complications and maximise the benefits of surgery.
Medical follow-up allows medication to be adjusted from the first few days and helps prevent hypoglycaemia. Nutritional deficiencies are also monitored and the diet is adapted.
Why choose our bariatric surgeon in Valencia for your treatment?
During a bariatric surgery consultation, type 2 diabetes and obesity are assessed individually. Multidisciplinary follow-up is tailored to each patient's needs before and after surgery.
Surgery is usually performed using a minimally invasive approach when indicated. The procedure and approach are chosen according to the clinical situation, without promising a specific reduction in complications.
You can request an assessment at the IMED centres listed on this website. Follow-up is tailored to the operation and your clinical and nutritional needs.
Individual results and follow-up
Individual results vary. A reduction in medication or an improvement in blood glucose must be documented through clinical monitoring; one person's experience cannot predict another person's progress.
To assess your prospects for improvement, bring your blood test results, current treatment and diabetes history to the consultation.

Conclusion: bariatric surgery as an investment in long-term health
Bariatric surgery represents an effective investment in long-term health for patients with type 2 diabetes and obesity. Its benefits go far beyond weight loss, offering a real opportunity for diabetes remission and an overall improvement in quality of life.
Surgery and medical treatment are options that can complement each other. If you have type 2 diabetes and obesity, request an assessment to compare benefits and risks; a future without diabetes cannot be promised.
Frequently asked questions about bariatric surgery and diabetes
When might diabetes improve? Blood glucose control can change within the first few days, making a medication review necessary. Confirming remission requires the laboratory and time criteria to be met; a single blood glucose reading is not enough.
Is remission permanent? Not necessarily. It may last for years, but diabetes can return. Blood glucose monitoring and checks for complications must continue, even when medication is no longer needed.
What are the risks? They include bleeding, gastrointestinal leaks, infection, thromboembolism and nutritional problems, among others. Their frequency depends on the procedure, the patient and the care setting; they are compared with the benefits and alternatives during the consultation.
IMED Valencia
Av. de la Ilustración, 1, 46100, Burjassot. Valencia
IMED Colón
C/ Isabel La Católica, 12. 46004 València
IMED Gandía
Carrer Ciutat de Barcelona, 29. 46702 Gandia, Valencia
https://www.instagram.com/drpauarago
Medical review of the Spanish source: Dr Pablo Aragó Chofre, Specialist in General and Digestive Surgery.
Spanish text review date: 11 November 2026.
General information for patients; assessment and treatment recommendations are tailored to each person during the consultation.
Medical sources: International consensus on type 2 diabetes remission, 2021 · ASMBS: indications for metabolic surgery.

